Shayla Bergmann, MD, is a clinical professor in pediatric hematology at the Medical University of South Carolina.
Targeted Therapies, Key Subgroup Insights to Watch at ASH 2025
New data in high-risk MDS, emerging menin inhibitors in AML, and evolving care needs in rare bleeding disorders set the stage for major ASH 2025 discussions.